Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3771 3774
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18040459 | Embolic Protection System | Final Rejection | The Medical College of Wisconsin, Inc. |
| 18227376 | IN-SITU FENESTRATION DEVICES WITH ARTICULATING ELEMENTS | Non-Final OA | Medtronic Vascular, Inc. |
| 18233007 | SYSTEMS AND METHODS TO INCREASE IMPLANTABLE DEVICE VOLUME FOR TREATMENT OF ANEURYSMS | Final Rejection | DePuy Synthes Products, Inc. |
| 18177648 | TREATMENT AID APPARATUS | Non-Final OA | TERUMO KABUSHIKI KAISHA |
| 18735648 | REPLACEMENT HEART VALVE SYSTEM AND METHOD OF TREATING A NATIVE HEART VALVE | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 17948933 | Embolic Protection Catheter and Related Devices and Methods | Non-Final OA | EmStop Inc. |
| 18926860 | STENT DEVICE | Non-Final OA | Vascutek Limited |
| 18247699 | Orbital Atherectomy System Having An Abrasive Element | Non-Final OA | Bard Peripheral Vascular, Inc. |
| 18138801 | FUNNEL CATHETER TIP WITH ANGLED FOLDING HOOPS | Non-Final OA | Neuravi Limited |
| 18793095 | WEARABLE GARMENT WITH BLOOD DETECTION AND AUTOMATED COMPRESSION ASSEMBLY | Non-Final OA | 0D Technologies, LLC |
| 17708570 | Sutures with External Filament Containing A Medicant | Final Rejection | Ethicon, Inc. |
| 17675779 | MULTIFUNCTIONAL LEFT ATRIAL APPENDAGE (LAA) OCCLUDER | Non-Final OA | Conformal Medical, Inc. |
| 18573444 | THREE JAW CLAMP APPARATUS AND SYSTEM FOR OCCLUSION AND EVERSION OF BLOOD VESSEL AND METHOD THEREOF | Final Rejection | SHIRA MEDTECH PRIVATE LIMITED |
| 18506305 | CONTROL OF IVL SYSTEMS, DEVICES AND METHODS THEREOF | Non-Final OA | Cardlovascular Systems, Inc. |
| 17036258 | EMBOLIC RETRIEVAL CATHETER | Non-Final OA | Incept, LLC |
| 17404027 | EMBOLIC BASKET, PARTICLES, AND RELATED METHODS | Non-Final OA | Michael Hallisey |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy